LOGO LOGO

Corestate

Newsroom

Back to overview

Press Releases of 12/12/2018

Corestate Capital Holding S.A.: CORESTATE enters into exclusive partnership with MEDICI LIVING, Europe's leading co-living provider

The cooperation plans to build a co-living portfolio worth EUR 1 billion across Europe within five years with investor money. As part of the cooperation, CORESTATE will identify, acquire and develop for its clients ideal sites and properties. The focus will be on cities in the German-speaking countries, Spain and Eastern Europe, with over 500,000 inhabitants and real estate with an investment volume of EUR 20 to 60 million. Several properties are already in the pipeline for the new product line. CORESTATE will benefit from its good market access and many years of experience in the micro living sector.

Corestate Capital Holding S.A.: CORESTATE enters into exclusive partnership with MEDICI LIVING, Europe's leading co-living provider

  • Entry into the fast-growing Co-Living segment
  • Planned expansion of a portfolio worth EUR 1 billion
  • Investment volume of EUR 20 to 60 million per property
  • Securing attractive, high-growth revenue structures

December 12, 2018: CORESTATE Capital Holding S.A. (CORESTATE), a leading European real estate investment manager, is expanding its Micro Living offering to include the fast-growing Co-Living segment. CORESTATE has entered into an exclusive partnership with the MEDICI LIVING Group, Europe's largest provider of innovative co-living concepts.

Under the QUARTERS brand, the MEDICI LIVING Group operates co-living spaces for creative people, young professionals and founders worldwide, including in New York, Amsterdam and Berlin. Its units offer users modern design, smart technology, spacious communal areas and regular events.

The cooperation plans to build a co-living portfolio worth EUR 1 billion across Europe within five years with investor money. As part of the cooperation, CORESTATE will identify, acquire and develop for its clients ideal sites and properties. The focus will be on cities in the German-speaking countries, Spain and Eastern Europe, with over 500,000 inhabitants and real estate with an investment volume of EUR 20 to 60 million. Several properties are already in the pipeline for the new product line. CORESTATE will benefit from its good market access and many years of experience in the micro living sector.

As part of the cooperation, MEDICI LIVING Group will prepare feasibility studies, support CORESTATE in property planning and design and fully assume operation. CORESTATE is securing long-term, high-growth revenue structures for itself and continuing to expand its market position in the trending area of "urban living."

"Together with MEDICI, we want to play a leading role in shaping the co-living market in Europe. Co-living properties optimally complement our current product range in the micro-living sector. It is a new, rapidly growing residential segment that covers millennials' rental requirements. They are looking to exchange ideas with like-minded people in a modern living space and experience community, no matter in which metropolis they are currently working. Our investors will also benefit from this trend. Through us, they have the opportunity to invest in a unique product range in the micro-living sector at European level," says Thomas Landschreiber, CIO and co-founder of CORESTATE.

Gunther Schmidt, founder and CEO of MEDICI LIVING Group, adds: "This partnership is the breakthrough for co-living in Europe". Gunther Schmidt sees even greater potential for the new asset class than for co-working. "The residential real estate market is much larger than that for office real estate," he adds. "We are building the WeWork of co-living and CORESTATE's investors can participate in it."

IR Contact
Dr. Kai Gregor Klinger
T: +49 69 3535630107 / M: +49 152 22755400
ir@corestate-capital.com

PR Contact
Andre Zahlten
T: +49 69 3535630-108 / M: +49 174 4022348
andre.zahlten@corestate-capital.com

About CORESTATE Capital Holding S.A.
CORESTATE Capital Holding S.A. (CORESTATE) is an investment manager and co-investor with approximately EUR 25bn in assets under management. As a fully integrated real estate platform, CORESTATE offers its clients combined expertise in the areas of investment and fund management as well as real estate management services. The company operates as a respected business partner of institutional clients and wealthy private investors internationally. CORESTATE is headquartered in Luxembourg and has 42 offices including in Frankfurt, London, Madrid, Singapore and Zurich. The company employs over 730 people and is listed in the Prime Standard (SDAX) of the Frankfurt Stock Exchange.

Forward-Looking Statements
This press release may contain forward-looking statements based on current assumptions and forecasts made by our management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of our company and the estimates given here. These factors include those discussed in our public reports, which are available on our website at [ir.corestate-capital.com]. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

 

04/12/2019

Ad Hoc Announcement: Corestate Capital Holding S.A. resolves on implementation of second tranche of announced share buy-back programme

04/04/2019

CORESTATE acquires further value-add commercial property in Munich

CORESTATE has acquired a further value-add commercial property in Munich with an investment volume of around EUR 54 million. The value creation potential of the property will be leveraged as part of CORESTATE’s manage-to-core strategy. The deal has already been signed, closing is scheduled for the end of May 2019.

04/01/2019

Ad Hoc Announcement: CORESTATE Capital Holding S.A. resolves on share buy-back programme

The management board of CORESTATE Capital Holding S.A. with its registered office in Luxembourg, ISIN LU1296758029 (the "Company") today resolved, with the consent of the supervisory board, to make use of the authorisation to purchase treasury shares as resolved by the annual general meeting of the Company on 27 April 2018 and to purchase up to 500,000 treasury shares in the period from 1 April 2019 to (and including) 25 April 2019.